Paul Proposes Letting Rx Makers Vary Discounts To Move Away From Rebates

Sen. Rand Paul (R-KY) on Tuesday (Dec. 12) proposed letting drug companies offer varying up-front discounts because doing so would move industry away from rebates that are blamed for obscuring business deals many lobbyists and policy analysts say contribute to price increases. Paul said allowing discounts directly from the manufacturer is a way to achieve price transparency without mandating it. Paul spoke at the Senate health committee’s third drug price hearing this year. Although Paul was the sole committee member...